S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in

NYSE:CSLT - Castlight Health Stock Price, Forecast & News

$1.38
-0.10 (-6.76 %)
(As of 01/20/2020 04:00 PM ET)
Today's Range
$1.38
Now: $1.38
$1.47
50-Day Range
$1.05
MA: $1.31
$1.54
52-Week Range
$1.01
Now: $1.38
$4.15
Volume391,028 shs
Average Volume697,380 shs
Market Capitalization$201.71 million
P/E RatioN/A
Dividend YieldN/A
Beta1.51
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services. Read More…

Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
Phone415-829-1400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$156.40 million
Cash Flow$0.02 per share
Book Value$1.37 per share

Profitability

Net Income$-39,710,000.00

Miscellaneous

Employees470
Market Cap$201.71 million
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable

Receive CSLT News and Ratings via Email

Sign-up to receive the latest news and ratings for CSLT and its competitors with MarketBeat's FREE daily newsletter.


Castlight Health (NYSE:CSLT) Frequently Asked Questions

What is Castlight Health's stock symbol?

Castlight Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CSLT."

How were Castlight Health's earnings last quarter?

Castlight Health Inc (NYSE:CSLT) released its quarterly earnings results on Thursday, October, 24th. The software maker reported ($0.04) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.04). The software maker had revenue of $35.46 million for the quarter, compared to analysts' expectations of $35.46 million. Castlight Health had a negative return on equity of 13.00% and a negative net margin of 21.68%. Castlight Health's revenue for the quarter was down 11.4% on a year-over-year basis. View Castlight Health's Earnings History.

When is Castlight Health's next earnings date?

Castlight Health is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Castlight Health.

What guidance has Castlight Health issued on next quarter's earnings?

Castlight Health issued an update on its FY 2019 After-Hours earnings guidance on Thursday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $145 million, compared to the consensus revenue estimate of $142.26 million.

What price target have analysts set for CSLT?

3 equities research analysts have issued 1 year price objectives for Castlight Health's stock. Their forecasts range from $1.20 to $1.50. On average, they anticipate Castlight Health's stock price to reach $1.35 in the next year. This suggests that the stock has a possible downside of 2.2%. View Analyst Price Targets for Castlight Health.

What is the consensus analysts' recommendation for Castlight Health?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Castlight Health in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Castlight Health.

Has Castlight Health been receiving favorable news coverage?

Headlines about CSLT stock have been trending extremely negative on Monday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Castlight Health earned a news sentiment score of -5.0 on InfoTrie's scale. They also gave press coverage about the software maker a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Castlight Health.

Are investors shorting Castlight Health?

Castlight Health saw a decrease in short interest during the month of December. As of December 31st, there was short interest totalling 1,630,000 shares, a decrease of 13.8% from the December 15th total of 1,890,000 shares. Based on an average daily volume of 796,300 shares, the short-interest ratio is presently 2.0 days. Approximately 1.6% of the shares of the stock are sold short. View Castlight Health's Current Options Chain.

Who are some of Castlight Health's key competitors?

What other stocks do shareholders of Castlight Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Castlight Health investors own include Gilead Sciences (GILD), Corbus Pharmaceuticals (CRBP), FireEye (FEYE), Ford Motor (F), Freeport-McMoRan (FCX), Verizon Communications (VZ), WPX Energy (WPX), Weyerhaeuser (WY), Akorn (AKRX) and Advanced Micro Devices (AMD).

Who are Castlight Health's key executives?

Castlight Health's management team includes the folowing people:
  • Dr. Bryan Eisman Roberts, Chairman (Age 52)
  • Mr. John C. Doyle, CEO & Director (Age 51)
  • Ms. Siobhan Nolan Mangini, Chief Financial Officer (Age 38)
  • Mr. M P Eric Chan, Chief Accounting Officer (Age 43)
  • Mr. Gary J. Fuges C.F.A., CFA, Head of Investor Relations

Who are Castlight Health's major shareholders?

Castlight Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Penbrook Management LLC (0.07%). Company insiders that own Castlight Health stock include John C Doyle, Maeve O'meara, Mangini Siobhan Nolan, MP Eric Chan, Neeraj Gupta, Seth B Cohen and William Bondurant. View Institutional Ownership Trends for Castlight Health.

Which institutional investors are selling Castlight Health stock?

CSLT stock was sold by a variety of institutional investors in the last quarter, including Penbrook Management LLC. Company insiders that have sold Castlight Health company stock in the last year include John C Doyle, Maeve O'meara, Mangini Siobhan Nolan, MP Eric Chan, Neeraj Gupta and William Bondurant. View Insider Buying and Selling for Castlight Health.

How do I buy shares of Castlight Health?

Shares of CSLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Castlight Health's stock price today?

One share of CSLT stock can currently be purchased for approximately $1.38.

How big of a company is Castlight Health?

Castlight Health has a market capitalization of $201.71 million and generates $156.40 million in revenue each year. The software maker earns $-39,710,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis. Castlight Health employs 470 workers across the globe.View Additional Information About Castlight Health.

What is Castlight Health's official website?

The official website for Castlight Health is http://www.castlighthealth.com/.

How can I contact Castlight Health?

Castlight Health's mailing address is 150 SPEAR STREET SUITE 400, SAN FRANCISCO CA, 94105. The software maker can be reached via phone at 415-829-1400 or via email at [email protected]


MarketBeat Community Rating for Castlight Health (NYSE CSLT)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  250 (Vote Outperform)
Underperform Votes:  330 (Vote Underperform)
Total Votes:  580
MarketBeat's community ratings are surveys of what our community members think about Castlight Health and other stocks. Vote "Outperform" if you believe CSLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CSLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel